相关实验视频
Updated: Jun 14, 2025

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.3K
连接组学和神经递质受体形状解释了阿尔茨海默病中区域性病理
Cerebral cortex (New York, N.Y. : 1991)
|March 14, 2025
概括
阿尔茨海默病的传播与神经递质受体密度有关. 较低的受体水平与较高的陶积累相关,这表明神经递质系统在疾病进展中的作用.
科学领域:
- 神经科学是一个神经科学.
- 放射学 放射学是一门学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 的特点是病理通过神经元通路传播.
- 突触活动的改变会影响的传播,但神经递质系统的作用仍然不清楚.
- 了解tau传播机制对于开发有效的AD疗法至关重要.
研究的目的:
- 为了研究神经递质受体密度和阿尔茨海默病中tau积累之间的关系.
- 确定神经递质受体概况是否增强了预测tau传播的模型.
- 用神经成像和受体数据解释区域对tau病理的敏感性.
主要方法:
- 利用休息状态功能磁共振成像 (fMRI) 连接学,神经递质受体PET成像和阿尔茨海默氏病神经成像计划 (ADNI) 的tau-PET数据.
- 分析了来自161个认知无障碍对照组和259个粉样β阳性阿尔茨海默病患者的数据.
- 使用线性回归来将tau-PET z分数与受体密度和连接模型联系起来.
主要成果:
- 较高的tau-PET z分数与色胺,多巴胺,GABA,乙胆和谷氨酸酸系统中的九个受体的密度较低相关.
- 在组级模型中,将四个神经递质受体密度z-score结合在内,可以将差异解释提高3-7%.
- 添加九个受体密度z-score将个人tau-PET变异性的解释能力提高了3-8%.
结论:
- 神经递质受体密度与阿尔茨海默病中tau积累有显著的相关性.
- 神经递质受体映射为基于连接性的tau传播模型增加了解释价值.
- 将神经成像与受体概况结合起来,可以更好地了解区域对病理的敏感性.
相关概念视频
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K

